End-of-day quote
Taiwan S.E.
03:30:00 29/04/2024 am IST
|
5-day change
|
1st Jan Change
|
40.4
TWD
|
+1.76%
|
|
+2.15%
|
+5.07%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7,043
|
7,989
|
9,041
|
11,879
|
15,327
|
16,168
|
Enterprise Value (EV)
1 |
9,083
|
10,318
|
10,136
|
13,588
|
15,562
|
15,701
|
P/E ratio
|
9.66
x
|
11.9
x
|
12.6
x
|
12.9
x
|
9.3
x
|
15.4
x
|
Yield
|
7.76%
|
6.84%
|
6.05%
|
6.37%
|
7.68%
|
7.28%
|
Capitalization / Revenue
|
0.39
x
|
0.47
x
|
0.52
x
|
0.64
x
|
0.67
x
|
0.85
x
|
EV / Revenue
|
0.5
x
|
0.6
x
|
0.58
x
|
0.73
x
|
0.68
x
|
0.82
x
|
EV / EBITDA
|
5.64
x
|
6.81
x
|
6.33
x
|
7.8
x
|
6.11
x
|
8.99
x
|
EV / FCF
|
12.1
x
|
8.24
x
|
5.82
x
|
-822
x
|
12.2
x
|
8.59
x
|
FCF Yield
|
8.26%
|
12.1%
|
17.2%
|
-0.12%
|
8.22%
|
11.6%
|
Price to Book
|
1.01
x
|
1.14
x
|
1.28
x
|
1.59
x
|
1.78
x
|
1.9
x
|
Nbr of stocks (in thousands)
|
4,20,492
|
4,20,492
|
4,20,492
|
4,20,492
|
4,20,492
|
4,20,492
|
Reference price
2 |
16.75
|
19.00
|
21.50
|
28.25
|
36.45
|
38.45
|
Announcement Date
|
28/03/19
|
23/03/20
|
22/03/21
|
18/03/22
|
24/02/23
|
23/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
18,134
|
17,081
|
17,484
|
18,646
|
23,043
|
19,113
|
EBITDA
1 |
1,610
|
1,515
|
1,601
|
1,743
|
2,548
|
1,747
|
EBIT
1 |
940.4
|
885.3
|
977.8
|
1,145
|
2,035
|
1,330
|
Operating Margin
|
5.19%
|
5.18%
|
5.59%
|
6.14%
|
8.83%
|
6.96%
|
Earnings before Tax (EBT)
1 |
892.9
|
845.7
|
851.1
|
1,155
|
2,144
|
1,381
|
Net income
1 |
727
|
674.9
|
715.6
|
920.9
|
1,650
|
1,053
|
Net margin
|
4.01%
|
3.95%
|
4.09%
|
4.94%
|
7.16%
|
5.51%
|
EPS
2 |
1.734
|
1.600
|
1.700
|
2.190
|
3.920
|
2.500
|
Free Cash Flow
1 |
750.6
|
1,252
|
1,743
|
-16.53
|
1,278
|
1,828
|
FCF margin
|
4.14%
|
7.33%
|
9.97%
|
-0.09%
|
5.55%
|
9.57%
|
FCF Conversion (EBITDA)
|
46.62%
|
82.68%
|
108.87%
|
-
|
50.17%
|
104.65%
|
FCF Conversion (Net income)
|
103.26%
|
185.59%
|
243.56%
|
-
|
77.47%
|
173.67%
|
Dividend per Share
2 |
1.300
|
1.300
|
1.300
|
1.800
|
2.800
|
2.800
|
Announcement Date
|
28/03/19
|
23/03/20
|
22/03/21
|
18/03/22
|
24/02/23
|
23/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,039
|
2,329
|
1,096
|
1,709
|
235
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
467
|
Leverage (Debt/EBITDA)
|
1.267
x
|
1.537
x
|
0.6843
x
|
0.9808
x
|
0.0921
x
|
-
|
Free Cash Flow
1 |
751
|
1,252
|
1,743
|
-16.5
|
1,278
|
1,828
|
ROE (net income / shareholders' equity)
|
10.7%
|
9.64%
|
10.2%
|
12.7%
|
20.5%
|
12.3%
|
ROA (Net income/ Total Assets)
|
3.89%
|
3.66%
|
4.04%
|
4.62%
|
7.81%
|
5.21%
|
Assets
1 |
18,673
|
18,427
|
17,693
|
19,922
|
21,128
|
20,210
|
Book Value Per Share
2 |
16.60
|
16.70
|
16.80
|
17.70
|
20.50
|
20.20
|
Cash Flow per Share
2 |
3.010
|
3.550
|
4.510
|
3.980
|
5.050
|
4.990
|
Capex
1 |
419
|
355
|
275
|
407
|
343
|
373
|
Capex / Sales
|
2.31%
|
2.08%
|
1.57%
|
2.18%
|
1.49%
|
1.95%
|
Announcement Date
|
28/03/19
|
23/03/20
|
22/03/21
|
18/03/22
|
24/02/23
|
23/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +5.07% | 521M | | +2.36% | 3.63B | | -17.31% | 2.23B | | -9.80% | 1.92B | | +3.66% | 1.88B | | -1.86% | 1.67B | | +2.91% | 1.17B | | -22.39% | 1.03B | | -4.02% | 993M | | +2.36% | 822M |
Pesticide
|